SETBP-1/SET/PP2A/p-ERK cascade is involved in type II interleukin 1 receptor associated regorafenib resistance that is overcome by MEK inhibitors in human colorectal cancer cells
2015 ◽
2016 ◽
2000 ◽
Vol 185
(2)
◽
pp. 293-301
◽
2013 ◽
Vol 32
(11)
◽
pp. 1178-1181
2016 ◽
Vol 24
◽
pp. 568-578
◽